GSK, Ionis Achieve Functional Cure in Hepatitis B Studies, Clearing Path for FDA Run Leave a Comment / By Leonardo Arias / 07/01/2026 Though specific data for bepirovirsen remain under wraps, GSK plans to file for approval in the first quarter of 2026.
